SPARC — Sun Pharma Advanced Research Co Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹83.52bn
- IN₹79.87bn
- IN₹2.39bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,454 | -3,124 | -1,511 | -2,034 | -2,226 |
Depreciation | |||||
Non-Cash Items | -293 | -0.399 | 387 | 65.1 | -47.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -47.1 | 922 | -504 | -215 | 1,465 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1,719 | -2,108 | -1,519 | -2,082 | -691 |
Capital Expenditures | -130 | -540 | -60 | -327 | -154 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -892 | 2,094 | 75.6 | 35.1 | -5,329 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,022 | 1,553 | 15.6 | -292 | -5,483 |
Financing Cash Flow Items | -1.03 | -19.5 | -81.3 | -223 | -77.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,742 | 555 | 1,593 | 2,293 | 6,168 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.47 | 0.027 | 89.5 | -80.8 | -6.41 |